From: Abstracts of 11th C1-inhibitor Deficiency & Angioedema Workshop
Sample (n) | 17 |
---|---|
Gender (n, %) | |
 Male | 4 (24%) |
 Female | 13 (76%) |
 Age, years (mean, range) | 43 (20–63) |
Diagnosis (n, %) | |
 Type 1 | 11 (64.7%) |
 Type 2 | 6 (35.3%) |
Treatment protocol (n, %) | |
 Prophylaxis | 11 (64.7%) |
 On-Demand | 6. (35.3%) |
Treatment administration (n, %) | |
 Self-administered treatment | 16 (94.1%) |
 Provider administered treatment | 1 (5.9%) |